Literature DB >> 11068816

Epidemiological, clinical and control investigations on field porcine coccidiosis: clinical, epidemiological and parasitological paradigms?

G P Martineau1, J del Castillo.   

Abstract

For several reasons, we are convinced that the parasitologist community must look again at porcine neonatal coccidiosis. We find it surprising that this disease is seldom addressed, and that assumptions are not always supported by clinico-epidemiological analysis. For example, the relationship between diarrhoea and the excretion of oocysts during experimental infection versus field infection is not questioned. Lindsay et al. review parasitological knowledge of this disease in the latest (1999) edition of Diseases of swine. Although this paper is divided into two parts, we have three distinct objectives: (1) to bring to the debate our experience in the medical control of this disease; (2) to propose a diagnostic methodology; (3) to raise some questions on various clinical, epidemiological and parasitological unknowns.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11068816     DOI: 10.1007/pl00008509

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  8 in total

1.  Isospora suis: an experimental model for mammalian intestinal coccidiosis.

Authors:  H-C Mundt; A Joachim; M Becka; A Daugschies
Journal:  Parasitol Res       Date:  2005-12-02       Impact factor: 2.289

Review 2.  Porcine isosporosis: infection dynamics, pathophysiology and immunology of experimental infections.

Authors:  Hanna L Worliczek; Marc Buggelsheim; Armin Saalmüller; Anja Joachim
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

3.  Age, not infection dose, determines the outcome of Isospora suis infections in suckling piglets.

Authors:  Hanna L Worliczek; Hans-Christian Mundt; Bärbel Ruttkowski; Anja Joachim
Journal:  Parasitol Res       Date:  2009-08       Impact factor: 2.289

4.  Control of piglet coccidiosis by chemical disinfection with a cresol-based product (Neopredisan 135-1).

Authors:  Evelyn Straberg; Arwid Daugschies
Journal:  Parasitol Res       Date:  2007-03-16       Impact factor: 2.289

5.  Which factors influence the outcome of experimental infection with Cystoisospora suis?

Authors:  Anja Joachim; Lukas Schwarz; Barbara Hinney; Bärbel Ruttkowski; Claus Vogl; Hans-Christian Mundt
Journal:  Parasitol Res       Date:  2014-03-19       Impact factor: 2.289

6.  Experimentally confirmed toltrazuril resistance in a field isolate of Cystoisospora suis.

Authors:  Aruna Shrestha; Barbara Freudenschuss; Rutger Jansen; Barbara Hinney; Bärbel Ruttkowski; Anja Joachim
Journal:  Parasit Vectors       Date:  2017-06-29       Impact factor: 3.876

7.  Factors associated with the occurrence and level of Isospora suis oocyst excretion in nursing piglets of Greek farrow-to-finish herds.

Authors:  Vasilis Skampardonis; Smaragda Sotiraki; Polychronis Kostoulas; Leonidas Leontides
Journal:  BMC Vet Res       Date:  2012-11-22       Impact factor: 2.741

8.  Comparison of an injectable toltrazuril-gleptoferron (Forceris®) and an oral toltrazuril (Baycox®) + injectable iron dextran for the control of experimentally induced piglet cystoisosporosis.

Authors:  Anja Joachim; Aruna Shrestha; Barbara Freudenschuss; Nicola Palmieri; Barbara Hinney; Hamadi Karembe; Daniel Sperling
Journal:  Parasit Vectors       Date:  2018-03-27       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.